Lots of excitement around BOT at present, in light of promising early results. However, they are a long long way from having regulator-approved safe & effective clinical products flying off the shelves. Also, in the biofilm-busting space for therapeutic products, NXS would seem to be well ahead of BOT, imho. Still, money can be made in short term SP sentiment...
Bot Chart, page-994
-
- There are more pages in this discussion • 13,284 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $651.6M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.3¢ | 36.0¢ | $154.2K | 428.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 201224 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 11825 | 2 |
View Market Depth
| Last trade - 10.26am 20/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |